Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
Open | $11.03 |
Close | $11.29 |
Volume / Avg. | 6.00M / 2.59M |
Day Range | $10.77 - $11.34 |
52 Wk Range | 9.02 - 14.57 |
Market Cap | $3.34B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 7.88% |
Days to Cover | 10.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amicus Therapeutics (NASDAQ:FOLD) through any online brokerage.
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX) and TG Therapeutics (NASDAQ:TGTX).
Amicus Therapeutics has a consensus price target of $16.00.
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $11.29 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Amicus Therapeutics.
Amicus Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Amicus Therapeutics.
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.